Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124821763 | 12482176 | 3 | F | 20160613 | 20160802 | 20160620 | 20160808 | EXP | PHHY2016BR083791 | NOVARTIS | 95.30 | YR | F | Y | 0.00000 | 20160808 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124821763 | 12482176 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG (9 MG/ 5 CM2 PATCH), QD | 667130 | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124821763 | 12482176 | 1 | Dementia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124821763 | 12482176 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124821763 | 12482176 | Altered state of consciousness | |
| 124821763 | 12482176 | Asthenia | |
| 124821763 | 12482176 | Blister | |
| 124821763 | 12482176 | Distractibility | |
| 124821763 | 12482176 | Eating disorder | |
| 124821763 | 12482176 | Product adhesion issue | |
| 124821763 | 12482176 | Somnolence | |
| 124821763 | 12482176 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |